Introduction to Meftinib 250mg Tablet

Meftinib 250mg Tablet is generally used for cancer management. It operates by attacking the epidermal growth factor receptor (EGFR) existing in both healthy and malignant cells, disrupting crucial signaling pathways for the proliferation of cancer cells.

Gefitinib is grouped under cancer drugs and is deployed to address certain types of cancers by curbing cancer cell proliferation. It homes in on the epidermal growth factor receptor (EGFR), that exists in both normal and cancerous cells. By obstructing particular proteins associated with this receptor, Gefitinib impedes the signal channels crucial for cancer cell proliferation and survival. Essentially, it puts a halt to the rampant proliferation of cancerous cells.

Adhere to the prescribed quantity and duration as instructed by your general physician. This medication can be consumed with or without meals but it is beneficial to maintain a regular time each day for best results.

Typical side effects might include diarrhea, arid skin, decreased appetite, queasiness, skin rash, stomatitis (inflammation in mouth), sickness, fatigue, and weight reduction.

It has been linked with an elevated danger of interstitial lung disease, a grave condition. Patients ought to be monitored for symptoms such as persistent cough, labored breathing, and high temperature. Immediate medical care is required if these symptoms manifest, and medication may need to be paused or halted.

Should a dosage be missed, consume it when remembered. However, if the subsequent dose is imminent, bypass the forgotten one and proceed with the regular dosage schedule. Refrain from doubling up on doses. Seek advice from your physician for managing forgotten doses efficiently.

Meftinib 250mg Tablet

How Meftinib 250mg Tablet Works?

Meftinib 250mg Tablet functions by restraining certain communication channels in cancer cells. It aims at an entity known as epidermal growth factor receptor (EGFR), present on both standard and cancer cells. By halting the initiation of particular proteins associated with this receptor, Gefitinib hampers the communication avenues that cancer cells depend on for expansion and survival. On a basic level, it's similar to deactivating the trigger that causes cancer cells to proliferate unmanageably, aiding in reducing or halting their growth.

How To Use Meftinib 250mg Tablet

  • Adhere to your physician's instructions for this drug, consume it in the indicated quantity and span.
  • The medication can be ingested with or without meals, but keeping a regular timing every day is suggested for superior outcomes.
  • Ingest the concoction undivided; abstain from masticating, pulverizing, or fracturing it.

Special Precautions About Meftinib 250mg Tablet

  • Gefitinib has been associated with an increased risk of interstitial lung disease, which can be serious Patients should be monitored for symptoms such as cough, difficulty breathing, and fever If symptoms occur, treatment may need to be interrupted or discontinued.
  • Gefitinib can affect liver function, leading to elevated liver enzymes Regular monitoring of liver function is recommended, and the drug may need to be adjusted or discontinued if liver abnormalities occur.

Benefits Of Meftinib 250mg Tablet

  • Tyrosine kinase inhibitor.
  • Used in the treatment of non-small cell lung cancer.
  • Inhibits cancer cell growth.
  • Prolongs survival in certain lung cancer cases.

Side Effects Of Meftinib 250mg Tablet

  • Diarrhea
  • Dry skin
  • Loss of appetite
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Vomiting
  • Weakness
  • Weight loss

What If I Missed A Dose Of Meftinib 250mg Tablet

If you miss a dose, take it when you remember. If your next dose is close, skip the missed one and stay on your regular schedule. Avoid taking two doses at once. Consult your doctor for guidance on managing missed doses effectively.

Similar Medicine Of Meftinib 250mg Tablet

For information purposes only. Consult a doctor before taking any medicines.

Geffy 250mg Tablet 10s

Intas Pharmaceuticals Ltd

Gefshil 250mg Tablet 10s

Shilpa Medicare Ltd

Chemogef 250mg Tablet 10s

Neon Laboratories Ltd

Gefifect 250mg Tablet 10s

Aureate Healthcare Pvt Ltd

Unigef 250mg Tablet 10s

Samarth Life Sciences Pvt Ltd

Geftib Tablet

Glenmark Pharmaceuticals Ltd

Gefifect 250mg Tablet 30s

Aureate Healthcare Pvt Ltd

Safety Advice For Meftinib 250mg Tablet

check for risk indication explain below.

  • High risk
  • Moderate risk.
  • Safe

Alcohol

It is dangerous to use alcohol concurrently with Meftinib 250mg Tablet due to the likelihood of adverse effects and increased risks.

Pregnancy

During pregnancy, Meftinib 250mg Tablet is considered unsafe, with definite proof of potential harm to the unborn child. Ask your doctor for alternatives in necessary circumstances.

Breast feeding

Caution is advised when breastfeeding and taking Meftinib 250mg Tablet. Limited data from humans indicates possible transmission via breast milk, creating a risk to the infant.

Kidney

Meftinib 250mg Tablet should be used with caution in severe kidney disease. Dose adjustments and personalized instructions should be discussed with your doctor.

Liver

Data suggests that Meftinib 250mg Tablet is likely safe to use in liver disease and does not require dose adjustment. However, it's best to consult your doctor when prescribed.

Alcohol

It is dangerous to use alcohol concurrently with Meftinib 250mg Tablet due to the likelihood of adverse effects and increased risks.

Pregnancy

During pregnancy, Meftinib 250mg Tablet is considered unsafe, with definite proof of potential harm to the unborn child. Ask your doctor for alternatives in necessary circumstances.

Breast feeding

Caution is advised when breastfeeding and taking Meftinib 250mg Tablet. Limited data from humans indicates possible transmission via breast milk, creating a risk to the infant.

Kidney

Meftinib 250mg Tablet should be used with caution in severe kidney disease. Dose adjustments and personalized instructions should be discussed with your doctor.

Liver

Data suggests that Meftinib 250mg Tablet is likely safe to use in liver disease and does not require dose adjustment. However, it's best to consult your doctor when prescribed.

Disease Explanation

thumbnail.sv

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. It occurs when abnormal cells grow and multiply in the lung tissues. NSCLC can be divided into three main types: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. NSCLC can cause symptoms such as coughing, chest pain, shortness of breath, and weight loss.